Neuphoria Therapeutics NEUP Ratios (2020-2026)

NASDAQ NEUP
$4.00 +0.05 (+1.24%)
As of: Aug 21, 2026 · 10:44 AM EDT
Ratios Jun2020 Jun2021 Jun2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -291.49%74.54%15,367.09%
EBIT Margin (Quarter) -558.84%79.85%43,981.65%
EBITDA Margin (Quarter) -558.84%79.85%43,981.65%
Operating Margin (Quarter) -558.84%79.85%43,981.65%
Net Margin (Quarter) -293.24%75.08%16,888.35%
FCF Margin (Quarter) -506.72%76.36%26,850.85%
Efficiency
Assets Average (Quarter) 21.25M44.28M37.76M25.28M20.54M24.44M29.65M27.97M31.97M35.70M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.20-10.88-21.3182.44-72.40-12.48
Times Interest Earned (Quarter) -0.20-10.88-21.3182.44-72.40-12.48
Valuation
Enterprise Value (Quarter) -3.00M-22.28M-24.04M-12.20M-8.14M-10.15M-8.43M-12.61M-8.08M-4.34M-17.04M-14.29M-13.68M-22.25M-19.44M
Return Ratios
Return on Sales (Quarter) -0.03%0.01%1.69%
Return on Capital Employed (Quarter) -70.35%-82.26%-3.37%-4.44%-14.07%-12.15%-49.02%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%